Affiliation: Hospital Universitari de Bellvitge
- A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled studyCesar Fisac
Endocrinology Services, Hospital Universitario de Bellvitge, 08907 L Hospitalet de Llobregat, Barcelona, Spain
J Clin Endocrinol Metab 88:5186-92. 2003..Inclusion of NVP should be considered when deciding upon antiretroviral regimens for patients at high coronary risk...
- Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapineCesar Fisac
Nutrition Section, Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain
AIDS 19:917-25. 2005..To evaluate the 24-month metabolic and morphological benefits obtained from replacing the protease inhibitor (PI) in a regimen with nevirapine, efavirenz or abacavir...
- Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized studyDaniel Podzamczer
Infectious Disease Service, Hospital Universitari de Bellvitge, Barcelona, Spain
J Acquir Immune Defic Syndr 44:139-47. 2007..To assess lipoatrophy, other toxicities, and efficacy associated with abacavir as compared with stavudine in HIV-infected antiretroviral-naive patients...
- Switching strategies to improve lipid profile and morphologic changesPatricia Barragan
Infectious Disease Service, Hospital Universitari de Bellvitge, L Hospitalet, Barcelona, Spain
AIDS Rev 8:191-203. 2006..In this setting, switching strategies may be useful to minimize clinical and psychological consequences, improving the quality of life of HIV-infected patients treated with HAART...